2007
DOI: 10.1016/j.bmc.2006.10.041
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and c-Src inhibitory activity of imidazo[1,5-a]pyrazine derivatives as an agent for treatment of acute ischemic stroke

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
33
0

Year Published

2007
2007
2020
2020

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 51 publications
(33 citation statements)
references
References 29 publications
0
33
0
Order By: Relevance
“…16) Therefore, the formation of imidazo [1,5-a] pyrazin-8(7H)-one derivatives (4) could be explained by the further reaction of the 3 with excessive TosMIC. Indeed, the reaction of 3a with TosMIC was reported to give 4a in high yield.…”
Section: Resultsmentioning
confidence: 99%
“…16) Therefore, the formation of imidazo [1,5-a] pyrazin-8(7H)-one derivatives (4) could be explained by the further reaction of the 3 with excessive TosMIC. Indeed, the reaction of 3a with TosMIC was reported to give 4a in high yield.…”
Section: Resultsmentioning
confidence: 99%
“…Previously, we reported that electron-donating substituents on the phenyl ring, especially the methoxy group, enhanced the c-Src inhibitory activity. 17) A single methoxy group at either the 3Ј-(7g) or 4Ј-position (7h) reduced the inhibitory activity against c-Src kinase compared to the dimethoxy derivative 7f. Removing the methoxy group on the aniline phenyl ring (7i) resulted in activity similar to that of monomethoxy derivatives 7g and 7h.…”
Section: Discovery Of Novel 2-anilinopyrazolo[15-a]pyrimidine Derivamentioning
confidence: 99%
“…Fused aromatic heterocycles are among the most important compound classes in drug discovery and also play a pivotal role in living organisms . In particular, such scaffolds can be found as building blocks for DNA (guanine and adenine) and also in many approved drugs, including sildenafil, zolpidem, and trazodone, and in medicinal chemistry studies (i.e., tyrosine kinase c‐Src inhibitors or P38α inhibitors ) (Fig. ).…”
Section: Introductionmentioning
confidence: 99%